-- 据深圳证券交易所周一发布的公告显示，深圳赛瑞斯制药（SHE:002294）旗下子公司赛瑞斯生物治疗公司在美国癌症研究协会年会上公布了其研发的JK06药物的积极疗效。 该药物已完成针对转移性肿瘤（包括非小细胞肺癌和乳腺癌）的I/II期临床试验。 试验期间，该药物在患者中显示出良好的安全性和有效性。 受此影响，赛瑞斯制药股价在午后交易中下跌4%。
Related Articles
Asia
Hefei Chipmore Technology to Invest Up to 800 Million Yuan in Wealth Products
Hefei Chipmore Technology (SHA:688352) plans to invest up to 800 million yuan in idle funds to purchase low-risk, short-term wealth management products, including structured deposits, time deposits and certificates of deposit.The funds can be used on a rolling basis over 12 months, according to a Monday filing with the Shanghai bourse.Shares of the integrated circuit packaging and testing services provider closed 2% higher Monday.
$SHA:688352
Asia
Koei Tecmo Raises Fiscal 2025 Forecasts on New Launches, Non-Operating Income Gains
Amusement and anime holding company Koei Tecmo (TYO:3635) has raised its attributable profit forecast for the fiscal year 2025 to 41.5 billion yen from 27 billion yen previously, according to a Tokyo bourse filing on Monday.Interim net income per share estimates for the year ended March were increased to 127.68 yen from 85.49 yen initially, but the net sales projection decreased to 87.5 billion yen from 92 billion yen.The upward revision was driven by new titles launched in the fourth quarter and other titles exceeding initial plans, which boosted net sales and operating profit.Additionally, significant gains in non-operating income and expenses resulting from active market management further lifted ordinary profit and profit attributable to owners of the parent.As a result, net sales, ordinary profit, and attributable profit are all expected to achieve record levels for the company.
$TYO:3635
Asia
Nomura Adjusts Dayamitra Telekomunikasi's Price Target to IDR675 From IDR750, Keeps at Buy
Dayamitra Telekomunikasi (IDX:MTEL) has an average rating of overweight and mean price target of 707.50 rupiah, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$IDX:MTEL